Cell Lysis and Disruption Market Industry Statistics, Progression Status, Emerging Demands, Recent Trends, Business Opportunity, Share and Forecast 2022 To 2031

Kenneth Research, in its repository of market research reports, have recently added a report on Cell Lysis and Disruption Market which emphasizes on the latest trends, key opportunities, drivers, and the challenges associated with the growth of the market during the forecast period, i.e., 2022 – 2031. The Cell Lysis and Disruption Marketis anticipated to grow primarily on account of the growing trade of ICT goods and services worldwide. According to the statistics by the World Bank, the exports of ICT goods globally increased from 11.164% of total goods exports in 2017 to 11.53% of total goods exports in 2019.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Cell Lysis and Disruption Market  products.

The Global Cell Lysis & Disruption Market is expected to cross USD 5.7 Billion by 2025 at a CAGR of 8.6%.Cell lysis & disruption is a method in which the cell membrane is broken down in order to extract the nucleic acids or proteins from a cell. The choice of cell lysis method depends on the type of cells, concentration, application (post-processing) and efficiency required. The demand for cell lysis & disruption is increasing due to the rising number of research & development activities in the biotechnology industry. This is majorly attributed to the increasing adoption of biotech processes in the pharmaceutical, agricultural sector.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159192

Market Influencer

The expansion of the biopharmaceutical sector and growing advancements in personalized medicine is positively influencing the market. Moreover, the rising demand for novel therapeutics and the increasing prevalence of diseases is responsible for positive market growth.

In 2018, the worldwide GDP stood at USD 84,740.3 Billion as compared to the GDP of USD 80,144.5 Billion in 2017, marked a growth of 5.73% in 2018 over previous year according to the data quoted by International Monetary Fund. This is likely to impel the growth of Keyword market over the period 2019-2026.

The Keyword market report also focuses on the analysis on the basis of geography which includes North America (U.S. and Canada), Latin America (Mexico, Brazil, Argentina, Rest of Latin America), Europe (Germany, UK, France, Spain, Italy, NORDIC, BENELUX, Poland, Russia, Hungary, Rest of Europe), Asia Pacific (China, Japan, India, Australia, New Zealand, South Korea, Malaysia, Indonesia, Rest of Asia Pacific) and Middle East and Africa (GCC, North Africa, South Africa and Rest of Middle East and Africa). In U.S., the GDP per capita was valued at USD 62,606 in 2018 as compared to USD 59,895 marked in 2017, observed a growth of 4.53% in 2018 over previous year. Rise in GDP per capita has intensified the growth of this market in the country

Market Drivers

Expanding biotechnology and biopharmaceutical industries. For example, the biotechnology industry in India is growing at a high pace. It comprises about 800 companies, is expected to be valued at USD 11.6 billion in 2017. Moreover, the government of India has invested USD 5 billion to initiate research in the field of biotechnology.The increasing prevalence of chronic diseases, including cancer. The incorporation of genetic and molecular techniques in personalized medicine via human genome research helps to determine best treatment options which are expected to drive the growth of cell lysis & disruption market.

Increasing government funding for research

Rising focus on personalized medicine

Technological advancements in cell disruption techniques

Market Restraints

Shortage of skilled personnel

The high maintenance cost of equipment


By Technique

Reagent Based: The largest segment, higher biological specificity of enzymatic disruption is attributive to the growth of this segment size. The reagent based segment is further segmented into detergent and enzymatic.Physical Disruption: Physical or mechanical methods of cell disruption have traditionally been the method of choice for cell lysis. Physical disruption method includes mechanical homogenization, ultrasonic homogenization, pressure homogenization, and temperature treatments.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159192

By Product

Consumables: The fastest-growing segment owing to the increasing prevalence of diseases and rise in funding of cell-based research is a crucial factor for the growth of the segment. Consumables are further divided into reagent and kits, beads, and disposables.Instruments: The commercial availability and reliability of tools that are used in cell disruption & lysis are boosting the growth of this segment. The instrument segment is further categorized as sonicators, homogenizers, French press, microfluidizer, and others.

By Cell Type

Mammalian Cells: The largest segment, this is attributable to Increased investments in R&D linked to biotechnology by government organizations and the private sector. Furthermore, the primary vital players have developed reagents that specifically work on mammalian cells, which is attributing to the growth of this segment. For instance, Merck offers a wide range of mammalian cell lysis reagents which are used for the preparation of mammalian phosphorylated, cytosolic, and nuclear proteins.Microbial Cells: The expansion of the biopharmaceutical sector and increasing research is responsible for positive growth.

Others: This segment covers plant cells.

By End-User

Research Laboratories and Institutes: The largest segment, increased use of cell disruption techniques in research facilities is projected to drive the growth of this segment during the forecast period.Pharmaceutical and Biotechnology Companies: A small segment due to the rising occurrence of diseases and growing research & development is projected to boost the growth of this segment.

Others: This segment includes academic and research institutions.

By Region

Americas: The largest regional market, increasing government initiatives to promote research in the pharmaceutical and biotech sector will boost the market growth in this region. Firms in the US conduct over half the world’s R&D in pharmaceuticals, which is about $75 billion and hold intellectual property rights on most new medicines.Europe: Technological advancements in personalized medicine and proteomic field is leading to a rise in the adoption of cell lysis & disruption techniques.

Request For Full Report- https://www.kennethresearch.com/sample-request-10159192

Asia-Pacific: The fastest-growing regional market, Asia-Pacific is seeing a surge in the clinical trials and contract research and manufacturing activities owing to the growth in the bio-services sector is expected to boost the market growth.Middle East & Africa: The smallest market due to limited healthcare infrastructure in this region.

Key Players

Thermo Fisher Scientific, Inc. (US)

Merck KGAA (Germany)

Bio-Rad Laboratories, Inc. (US)

Danaher Corporation (US)

Becton Dickinson & Company (US)

Cell Signaling Technology, Inc. (US)

Miltenyi Biotec (Germany)

Hoffmann–La Roche Ltd. (Switzerland)

Qiagen N.V. (Netherlands)

Qsonica, LLC (US)

About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us
Name: Kenneth research
Phone: +1 313 462 0609

Endodontics Treatments Industry Market
Virtual Patient Simulation Industry Market
Cell therapy Processing Industry Market
Gastric Cancer Testing, Treatment and Prevention Industry Market
Transcatheter Mitral Valve Replacement (TMVR) Industry Market

Related posts

Leave a Comment